Fluvoxamine treatment of a child with severe PDD: a single case study.

Recent reports suggest that selective serotonin reuptake inhibitors (SSRIs) are useful in the treatment of individuals with autism and other pervasive developmental disorders. We report on a single case study of the use of fluvoxamine with a 7-year-old Caucasian girl with severe pervasive developmental disorder. Our findings indicate that fluvoxamine was significantly effective in reducing stereotypical, repetitive behaviors, anxiety, and aggression and in improving prelinguistic and social behaviors. Our results indicate that the use of the SSRIs as a platform for the long-term habilitation of these children should be considered, but further studies are required to establish the efficiency of fluvoxamine for the treatment of children with autism.
AuthorsC Kauffmann, H Vance, A J Pumariega, B Miller
JournalPsychiatry (Psychiatry) Vol. 64 Issue 3 Pg. 268-77 ( 2001) ISSN: 0033-2747 [Print] United States
PMID11708052 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Serotonin Uptake Inhibitors
  • Fluvoxamine
  • Child
  • Child Development Disorders, Pervasive (diagnosis, drug therapy)
  • Female
  • Fluvoxamine (therapeutic use)
  • Humans
  • Serotonin Uptake Inhibitors (therapeutic use)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: